Dividend King Growth Giant: J&J Faces Lilly Challenge
Johnson & Johnson and Eli Lilly reported contrasting Q1 2026 results, pitting a durable, dividend-focused giant again...
Learn the key factors to inspect when comparing funds, including costs, performance, and risk, to make informed investment choices.
18,912 articlesJohnson & Johnson and Eli Lilly reported contrasting Q1 2026 results, pitting a durable, dividend-focused giant again...
MicroStrategy is monetizing BTC to back dividends and bolster liquidity, draining a portion of its planned sale capac...
Investors are turning to dividend-growth stocks to build a rising income stream that can outpace inflation over a dec...
SpaceX shares moved lower even as a wave of bullish analyst initiations hit the tape. The sector’s rhythm remains vol...
Solana’s on-chain data show real-world asset transfers surging to $8.68 billion in the last 30 days, with asset value...
An 89-year-old retiree who started retirement with million has seen a $1 million drop from a $3 million nest egg. Wit...
July markets bring attention to enduring brands and steady income. Coca-Cola's blend of dividend discipline, pricing ...
A prominent Canadian self-made investor argues Canadians give far less to charity than Americans, highlighting a pers...
As July 18, 2026 approaches, the GENIUS Act deadline accelerates rulemaking for stablecoin issuers. Regulators from T...
The Senate faces a stalled path for the Digital Asset Market Clarity Act as Democrats push a stiff ethics provision, ...
On the nation’s 250th birthday, economists and market experts outline ten reasons why America’s economy looks poised ...
Amid slower housing demand and higher costs, regional and mid-sized builders are leaning on flexible financing to sus...